Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.

Source:http://linkedlifedata.com/resource/pubmed/id/19512976

Download in:

View as

General Info

PMID
19512976